Cardiac amyloidosis red flags: What all the cardiologist have to know
Open Access
- 27 April 2024
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 21, 200271
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Patisiran Treatment in Patients with Transthyretin Cardiac AmyloidosisNew England Journal of Medicine, 2023
- 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac AmyloidosisJACC, 2023
- Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesEuropean Heart Journal, 2021
- Inotersen therapy of transthyretin amyloid cardiomyopathyAmyloid, 2019
- Tafamidis Treatment for Patients with Transthyretin Amyloid CardiomyopathyNew England Journal of Medicine, 2018